CAN
TGTX icon

Cetera Advisor Networks’s TG Therapeutics TGTX Stock Holding History

Cetera Advisor Networks’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$313K Sell
20,572
-21,718
-51% -$346K ﹤0.01% 2255
2023
Q4 		$722K Buy
42,290
+25,233
+148% +$293K ﹤0.01% 1600
2023
Q3 		$143K Buy
+17,057
New +$238K ﹤0.01% 2506
2020
Q3 		– Sell
-3,508
Closed -$68K – 2852
2020
Q2 		$68K Buy
+3,508
New +$56.5K ﹤0.01% 1736

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cetera Advisor Networks's TGTX Position: Q1 2024 in Review

Cetera Advisor Networks reduced its TG Therapeutics (TGTX) stake by 51% in Q1 2024, selling an estimated $346K and leaving 20,572 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Cetera Advisor Networks first reported a position in TGTX in Q2 2020 and has held it in 4 quarters since. The position peaked at $722K in Q4 2023. 243 funds tracked by Wall St. Rank hold TGTX as of Q1 2024.

  • Cetera Advisor Networks held 20,572 shares of TG Therapeutics worth $313K as of Q1 2024.
  • Cetera Advisor Networks sold 21,718 TG Therapeutics shares in Q1 2024, an estimated $346K.
  • TG Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2255 holding.
  • Cetera Advisor Networks first reported a position in TG Therapeutics in Q2 2020 and has held it in 4 quarters since.
  • Cetera Advisor Networks's TG Therapeutics position peaked at $722K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.